Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Aphios obtains funding from NIAID to develop cure for HIV/AIDS

Sep. 15, 2016

Janssen-Cilag submits MAA to EMA for darunavir-based single tablet regimen

Sep. 13, 2016

New York Blood Center patents anti-HIV antibody-drug conjugates

Sep. 8, 2016

European Commission grants marketing authorization to Gilead's Truvada

Aug. 23, 2016

Viiv Healthcare starts phase III trial for two-drug regimen of dolutegravir/lamivudine

Aug. 18, 2016

Genmab and Gilead Sciences enter DuoBody license agreement

Aug. 11, 2016

ANXA1 signaling as a novel therapeutic target for the resolution of immune dysfunction in HIV

Aug. 11, 2016

NIH awards a new contract to the IAVI to advance AIDS vaccine development

Aug. 10, 2016

GeoVax awarded contract from NIH to further develop HIV vaccine

Aug. 3, 2016

Janssen files for approval of darunavir/cobicistat combination tablets in Japan

July 29, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...